Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis

被引:24
|
作者
Cai, Dasheng [1 ]
Zhao, Yue [2 ]
Yu, Fang [1 ]
机构
[1] China Med Univ, Dept Anesthesiol, Hosp 1, Shenyang, Peoples R China
[2] Liaoning Univ Tradit Chinese, Dept Anesthesiol, Affiliated Hosp 2, Shenyang, Peoples R China
关键词
PROTEIN PHOSPHATASE 2A; CRYSTAL-STRUCTURE; PP2A; ACTIVATION; EXPRESSION;
D O I
10.1038/s41420-022-01137-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We commenced to analyze putative anti-pyroptosis effects of puerarin (PU) as mediated by the PP2A-HDAC1-NLRP3 pathway in acute lung injury (ALI). ALI animal and cell models were constructed, followed by treatment of PU. Then, the effect of HDAC1, PP2A, and NLRP3 on cell inflammation and pyroptosis was explored. The interaction between HDAC1 and PP2A as well as between PP2A and NLRP3 was analyzed. Our findings suggested that PU downregulated HDAC1 expression to alleviate symptoms of ALI. HDAC1 overexpression promoted inflammation induced by LPS, which reversed the inhibitory effect of PU on ALI. HDAC1 overexpression also decreased PP2A expression, suggesting that PP2A was involved in the effects of HDAC1 on LPS-induced inflammation. PP2A exerted inhibitory effects on NLRP3. Meanwhile, PU hindered the progression of ALI by silencing HDAC1 or overexpressing PP2A both in vivo and in vitro. Taken together, PU restrained pyroptosis of cells induced by NLRP3 inflammasome to abate ALI.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Puerarin ameliorates acute lung injury by modulating NLRP3 inflammasome-induced pyroptosis
    Dasheng Cai
    Yue Zhao
    Fang Yu
    Cell Death Discovery, 8
  • [2] NLRP3 inflammasome-induced pyroptosis in digestive system tumors
    Wen, Jiexia
    Xuan, Bin
    Liu, Yang
    Wang, Liwei
    He, Li
    Meng, Xiangcai
    Zhou, Tao
    Wang, Yimin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Acute Lung Injury and the NLRP3 Inflammasome
    Gu, Wanjun
    Zeng, Qi
    Wang, Xin
    Jasem, Huthaifa
    Ma, Ling
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3801 - 3813
  • [4] Tanshinone IIA ameliorates acute lung injury by inhibition of the NLRP3 inflammasome
    Chen, Tianyu
    Qin, Shaoyun
    Dai, Ying
    ARCHIVES OF BIOLOGICAL SCIENCES, 2019, 71 (02) : 315 - 320
  • [5] Berberine alleviates influenza viral pneumonia by inhibiting the NLRP3 inflammasome-induced pyroptosis
    Chen, A.
    Huan-wei, L.
    Si-yao, Z.
    Lei-ming, Y.
    Jun, W.
    Hao, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1913 - 1914
  • [6] TREM-1 inhibition or ondansetron administration ameliorates NLRP3 inflammasome and pyroptosis in traumatic brain injury-induced acute lung injury
    Li, Fen
    Qin, Na
    Yu, Yiqin
    Dong, Rui
    Li, Xiaojie
    Gong, Shenhai
    Zeng, Zhenhua
    Huang, Lin
    Yang, Hong
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (03) : 984 - 996
  • [7] Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation
    Jiang, Lei
    Zhang, Lei
    Kang, Kai
    Fei, Dongsheng
    Gong, Rui
    Cao, Yanhui
    Pan, Shangha
    Zhao, Mingran
    Zhao, Mingyan
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 130 - 138
  • [8] NLRP3 inflammasome-induced pyroptosis and serum ASC specks are increased in patients with cardiogenic shock
    Kogel, Alexander
    Baumann, Lisa
    Maeder, Christina
    Buettner, Petra
    Thiele, Holger
    Kneuer, Jasmin M.
    Boeckel, Jes-Niels
    Laufs, Ulrich
    Gaul, Susanne
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (04): : H869 - H879
  • [9] Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
    Shan, Mengtian
    Wan, Huimin
    Ran, Linyu
    Ye, Jihui
    Xie, Wang
    Lu, Jingjing
    Hu, Xueping
    Deng, Shengjie
    Zhang, Wenyu
    Chen, Miao
    Wang, Feilong
    Guo, Zhongliang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1369 - 1384
  • [10] BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis
    Hua, Tong
    Wang, Haowei
    Fan, Xiaoyi
    An, Ni
    Li, Jian
    Song, Honghao
    Kong, Erliang
    Li, Yongchang
    Yuan, Hongbin
    FRONTIERS IN IMMUNOLOGY, 2022, 13